ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0837

Deletion of miR-223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice

Sumie Hiramatsu Asano1, Tomoyuki Mukai2, Yoshitaka Morita3 and Jun Wada4, 1Kawasaki Medical School/Department of Rheumatology, Kurashiki city, Japan, 2Kawasaki Medical School, Kurashiki-shi, Okayama, Japan, 3Kawasaki Medical School/Department of Rheumatology, Kurashiki, Okayama, Japan, 4Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences., Okayama city, Japan

Meeting: ACR Convergence 2020

Keywords: Apoptosis, Epigenetics, Nephritis, Systemic lupus erythematosus (SLE), T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: SLE – Animal Models Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: To identify new candidate genes regulated by micro RNAs (miRNAs) and involved in the pathogenesis of systemic lupus erythematosus (SLE), we integrated miRNA and messenger RNA (mRNA) expression profiling data in CD4+ splenic T cells derived from lupus-prone MRL/MpJ-Faslpr /J (MRL/lpr) mice and C57BL6/J (B6) mice. The reduction of sphingosine-1-phosphate receptor 1 (S1pr1) and upregulation of miR-223-3p in the splenic T cells in MRL/lpr was identified and we investigated the role of S1pr1 as a predicted target of miR-223 (Mir223) in SLE.

Methods: L transduction particles containing luciferase reporter and S1pr1-3’UTR region was infected into human umbilical vein endothelial cells (HUVECs) for luciferase miRNA target screening. Luciferase reporter assay following co-transfection of lentiviral particles containing reporter vector with miR-223-3p mimic or nontargeting miRNA into HUVECs was performed. To further confirm that S1pr1 is a target of miR-223-3p, miR-223-3p mimic or nontargeting miRNA was transfected into EL4 mouse T cell lines by lipofection. The transfection efficacy of miR-223-3p was confirmed by quantitative PCR (qPCR). The endogenous S1pr1 mRNA and protein levels were detected by qPCR and Western blot analysis. To explore the involvement of miR-223-3p in SLE pathogenesis, we generated and analyzed Mir223 knockout lupus-prone B6.MRL-Faslpr mice (Mir223-/-Faslpr/lpr) until 44 weeks of age. The total IgG and titer of anti-ds-DNA antibodies in serum were measured by ELISA. Histopathological grading of glomerular, renal vascular and tubulointerstitial lesions were performed and the glomerular immune complex deposition was assessed by C3 and IgG staining. To clarify the cell types which infiltrates in glomerular lesion, immunofluorescence staining with CD4, CD8 and S1PR1 antibodies was performed. The cell population including apoptotic cells and S1PR1 positive cells in the lymph nodes and spleen were analyzed by flow cytometry. We also investigated the expression levels of S1pr1 mRNA and miR-223-3p in circulating CD4+ T cells isolated from SLE patients and healthy subjects.

Results: Transfection of HUVEC with mimic miR-223-3p significantly suppressed a luciferase-reporter containing the S1pr1-3’UTR. The mRNA levels of S1pr1 was significantly decreased after miR-223-3p overexpression. Mir223 deficiency increased the production of serum IgG2b and the proportion of CD3+ T cells, CD3+CD4–CD8– T cells, CD19+ B cells, CD19–CD138+ cells (Plasma cells), CD3+S1PR1+ T cells and CD3+CD4+S1PR1+ T cells in spleen and the proportion of early apoptotic cells in CD4+ and CD8+ T cells in lymph nodes. Lupus nephritis in Mir223 knockout mice was exacerbated accompanied with glomerulonephritis with infiltration of CD4+S1PR1+ T cells in glomerulus. S1pr1 mRNA was significantly decreased in CD4+ T cells from the patients with SLE. miR-223-3p tended to upregulate in lupus patients than healthy control. There was significant correlation between miR-223-3p and serum IgM titer.

Conclusion: Deletion of Mir223 exacerbated the lupus phenotypes associated with increasing S1pr1 expression in CD4+T cells and their enhanced infiltration in inflamed kidney tissues.


Disclosure: S. Hiramatsu Asano, None; T. Mukai, None; Y. Morita, None; J. Wada, None.

To cite this abstract in AMA style:

Hiramatsu Asano S, Mukai T, Morita Y, Wada J. Deletion of miR-223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/deletion-of-mir-223-exacerbates-lupus-nephritis-by-targeting-s1pr1-in-faslpr-lpr-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deletion-of-mir-223-exacerbates-lupus-nephritis-by-targeting-s1pr1-in-faslpr-lpr-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology